Report: Target Product Profiles: Physician Insights on Key Attributes - Acute Ischemic Stroke, IV reperfusion agent approved for use within six hours of acute ischemic stroke. TOC

Target Product Profiles: Physician Insights on Key Attributes - Acute Ischemic Stroke, IV reperfusion agent approved for use within six hours of acute ischemic stroke.

Published by

Decision Resources, Inc.

Published

2008/03

Content info

35 Pages

Product code

DR64867

Price

From US $ 5625

PDF by E-Mail

Approx. 1-2 business days

Hard Copy/CD-ROM

Approx. 3-4 business days

If you need expedited delivery, please call us.

Introduction
- Using Target Product Profiles in Your Market Strategy
- Report Contents
- Target Product Profile Methodology
Etiology and Pathophysiology
- Etiology
  - Thrombosis
  - Embolism
  - Small Penetrating Artery Disease
- Pathophysiology
  - The Therapeutic Time Window
  - Ischemic Cascade
  - Toxic Events Following Prolonged Ca++ Influx
Target Product Profile Discussion - Acute Ischemic Stroke
- Target Product Profile Summary for Acute Ischemic Stroke - 2011
- Assessing Drug Development Opportunities
- Physician Survey Results
  - Efficacy
  - Safety and Tolerability
  - Delivery
  - Estimated Patient Share
- Pricing Potential
- Forecasted 2016 Pricing Environment
- Competitors to Watch
- Emerging Product Profiles

Target Product Profiles: Physician Insights on Key Attributes - Acute Ischemic Stroke, IV reperfusion agent approved for use within six hours of acute ischemic stroke.

Table of Contents